Your browser doesn't support javascript.
loading
What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
Lawrance, Rachael; Degtyarev, Evgeny; Griffiths, Philip; Trask, Peter; Lau, Helen; D'Alessio, Denise; Griebsch, Ingolf; Wallenstein, Gudrun; Cocks, Kim; Rufibach, Kaspar.
Afiliação
  • Lawrance R; Adelphi Values Ltd, Bollington, UK. rachael.lawrance@adelphivalues.com.
  • Degtyarev E; Novartis Pharma AG, Basel, Switzerland.
  • Griffiths P; Adelphi Values Ltd, Bollington, UK.
  • Trask P; Genentech, San Francisco, CA, USA.
  • Lau H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • D'Alessio D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Griebsch I; Boehringer-Ingelheim International GmbH, Ingelheim, Germany.
  • Wallenstein G; Boehringer-Ingelheim International GmbH, Ingelheim, Germany.
  • Cocks K; Adelphi Values Ltd, Bollington, UK.
  • Rufibach K; F.Hoffmann-La Roche, Basel, Switzerland.
J Patient Rep Outcomes ; 4(1): 68, 2020 Aug 24.
Article em En | MEDLINE | ID: mdl-32833083
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article